A detailed history of Org Wealth Partners, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Org Wealth Partners, LLC holds 18,240 shares of ROIV stock, worth $203,376. This represents 0.15% of its overall portfolio holdings.

Number of Shares
18,240
Previous 9,823 85.69%
Holding current value
$203,376
Previous $113 Million 99.81%
% of portfolio
0.15%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 10, 2025

BUY
$11.16 - $12.71 $93,933 - $106,980
8,417 Added 85.69%
18,240 $215,000
Q3 2024

Oct 11, 2024

BUY
$10.17 - $12.5 $99,899 - $122,787
9,823 New
9,823 $113 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.85B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Org Wealth Partners, LLC Portfolio

Follow Org Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Wealth Partners, LLC with notifications on news.